Trial Search Results
Steroids After Laser Trabeculoplasty for Glaucoma
The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Stanford University
Collaborator: University of Pittsburgh Medical Center
Stanford Investigator(s):
Intervention(s):
- Drug: Prednisolone 1%
- Drug: Ketorolac
- Drug: Artificial Tears
Phase:
Phase 4
Eligibility
Inclusion Criteria:
- clinical diagnosis of glaucoma
- clinician has determined that SLT laser is indicated
- IOP currently >18 and was ever >21 in the past (e.g. prior to treatment)
Exclusion Criteria:
- prior history of uveitis
- prior glaucoma surgery including glaucoma laser surgery
- pregnant or 3 months post-partum
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting